Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Bedossa

Showing results (181-190 of 267) with videos related to

Pageof 27
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 10, 2023
Prospective Comparison of Attenuation Imaging and Controlled Attenuation Parameter for Liver Steatosis Diagnosis in Patients With Nonalcoholic Fatty Liver Disease and Type 2 DiabetesMarco Dioguardi Burgio, Laurent Castera, Mehdi Oufighou, et al.
Lipids in Health and Disease|February 25, 2017
Dietary intervention, but not losartan, completely reverses non-alcoholic steatohepatitis in obese and insulin resistant miceJef Verbeek, Pieter Spincemaille, Ilse Vanhorebeek, et al.
Hepatology (Baltimore, Md.)|December 31, 2008
Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patientsRami Moucari, Vincent Mackiewicz, Olivier Lada, et al.
Journal of Hepatology|April 21, 2009
High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up studyRami Moucari, Anneke Korevaar, Olivier Lada, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 23, 2015
Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis BMartine Lapalus, Cédric Laouenan, Ana-Carolina Cardoso, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 13, 2016
Hepatocellular autophagy modulates the unfolded protein response and fasting-induced steatosis in miceWilhelmus J Kwanten, Yves-Paul Vandewynckel, Wim Martinet, et al.
JHEP Reports : Innovation in Hepatology|March 11, 2026
The Elucidating Pathways of Steatohepatitis (EPoS) staging system: A reproducible 7-tiered fibrosis scoring system in MASLDDina G Tiniakos, Pierre Bedossa, Johanna Arola, et al.
Journal of Clinical Pathology|October 29, 2025
AI portal tract detection and characterisation for a regional analysis of steatosis and inflammation in MASLD, MASH and AIHDylan Windell, Alastair Magness, Cayden Beyer, et al.
Scientific Reports|October 13, 2016
MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and CKevin Appourchaux, Safi Dokmak, Matthieu Resche-Rigon, et al.
Nature Communications|August 26, 2023
Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis testsJérôme Boursier, Marine Roux, Charlotte Costentin, et al.
Pageof 27

Showing results (181-190 of 267) with videos related to

Sort By:
Pageof 27
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 10, 2023
Prospective Comparison of Attenuation Imaging and Controlled Attenuation Parameter for Liver Steatosis Diagnosis in Patients With Nonalcoholic Fatty Liver Disease and Type 2 DiabetesMarco Dioguardi Burgio, Laurent Castera, Mehdi Oufighou, et al.
Lipids in Health and Disease|February 25, 2017
Dietary intervention, but not losartan, completely reverses non-alcoholic steatohepatitis in obese and insulin resistant miceJef Verbeek, Pieter Spincemaille, Ilse Vanhorebeek, et al.
Hepatology (Baltimore, Md.)|December 31, 2008
Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patientsRami Moucari, Vincent Mackiewicz, Olivier Lada, et al.
Journal of Hepatology|April 21, 2009
High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up studyRami Moucari, Anneke Korevaar, Olivier Lada, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 23, 2015
Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis BMartine Lapalus, Cédric Laouenan, Ana-Carolina Cardoso, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 13, 2016
Hepatocellular autophagy modulates the unfolded protein response and fasting-induced steatosis in miceWilhelmus J Kwanten, Yves-Paul Vandewynckel, Wim Martinet, et al.
JHEP Reports : Innovation in Hepatology|March 11, 2026
The Elucidating Pathways of Steatohepatitis (EPoS) staging system: A reproducible 7-tiered fibrosis scoring system in MASLDDina G Tiniakos, Pierre Bedossa, Johanna Arola, et al.
Journal of Clinical Pathology|October 29, 2025
AI portal tract detection and characterisation for a regional analysis of steatosis and inflammation in MASLD, MASH and AIHDylan Windell, Alastair Magness, Cayden Beyer, et al.
Scientific Reports|October 13, 2016
MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and CKevin Appourchaux, Safi Dokmak, Matthieu Resche-Rigon, et al.
Nature Communications|August 26, 2023
Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis testsJérôme Boursier, Marine Roux, Charlotte Costentin, et al.
Pageof 27